SCHEMBL6613201

SCHEMBL6613201

CC(=O)Cl.COc1cc(OC2CCN(C(C)=O)CC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1

nearest known ligand 0.97

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 0.97
SRC P12931 1/20 0.55
ERBB2 P04626 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4039655 0.98 EGFR (1.00) EGFRSRCERBB2
SCHEMBL4040983 0.89 EGFR (0.82) EGFRSRCERBB2
SCHEMBL5662811 0.88 EGFR (0.81) EGFRSRCERBB2
SCHEMBL2494257 0.88 EGFR (0.81) EGFRSRCERBB2
SCHEMBL4034609 0.88 EGFR (1.00) EGFRSRCERBB2
SCHEMBL4036906 0.87 EGFR (0.85) EGFRSRCERBB2
SCHEMBL5662719 0.87 EGFR (0.79) EGFRSRCERBB2
SCHEMBL4034575 0.86 EGFR (0.78) EGFRSRCERBB2
SCHEMBL4034383 0.86 EGFR (1.00) EGFRSRCERBB2
SCHEMBL4034115 0.85 EGFR (0.83) EGFRSRCERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444211-A2 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2004-08-11 EP disclosed
WO-2003040109-A2 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2003-05-15 WO disclosed